BRCA germline mutation test for all woman with ovarian cancer?

BACKGROUND: Delivering widespread BRCA testing to patients with ovarian cancer has been suggested by several scientists, recommended by professional societies and solicited by patients organizations. However, based on the lack of studies clearly demonstrating the cost-effectiveness of such approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Paradiso, A. V., Digennaro, M., Patruno, M., De Summa, S., Tommasi, S., Berindan-Neagoe, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599356/
https://www.ncbi.nlm.nih.gov/pubmed/31253107
http://dx.doi.org/10.1186/s12885-019-5829-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599356/
https://www.ncbi.nlm.nih.gov/pubmed/31253107
http://dx.doi.org/10.1186/s12885-019-5829-4

Ejemplares similares